Vitamins D and K in the Treatment of Osteoporosis Secondary to Graft-versus-host Disease Following Bone-marrow Transplantation

Author： Hattori M   Morita N   Tsujino Y   Yamamoto M   Tanizawa T  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.29, Iss.4, 2001-07, pp. : 381-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Graft-Versus-Host Disease in Paediatric Bone Marrow Transplant Recipients

By Zecca M.   Locatelli F.  

Pediatric Drugs, Vol. 2, Iss. 1, 2000-01 ,pp. : 29-55

Adis International

Access to resources Recommend Favorite

Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation

By McDonald George B  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1709-1724

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutics for the treatment of graft-versus-host disease

By Jacobsohn David A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1271-1280

Informa Healthcare

Access to resources Recommend Favorite

Denileukin diftitox has promising activity in graft-versus-host disease (GVHD) following haematopoietic stem cell transplantation

By  

Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Links Between Cyclosporin Exposure in Tissues and Graft-Versus-Host Disease in Pediatric Bone Marrow Transplantation: Analysis by a PBPK Model

By Gérard Cécile   Bleyzac Nathalie   Girard Pascal   Freyer Gilles   Bertrand Yves   Tod Michel  

Pharmaceutical Research, Vol. 28, Iss. 3, 2011-03 ,pp. : 531-539

Springer Publishing Company

Access to resources Recommend Favorite